Ishares Pharmaceuticals Etf Buy Hold or Sell Recommendation
| IHE Etf | USD 68.80 0.34 0.50% |
Considering the 90-day investment horizon and your typical level of risk aversion, our recommendation regarding iShares Pharmaceuticals ETF is 'Hold'. Macroaxis provides IShares Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IHE positions.
Check out IShares Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual funds such as IShares and provide practical buy, sell, or hold recommendation based on investors' investing horizon and their risk tolerance towards iShares Pharmaceuticals ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate.
IShares |
Execute IShares Pharmaceuticals Buy or Sell Advice
The IShares recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on iShares Pharmaceuticals ETF. Macroaxis does not own or have any residual interests in iShares Pharmaceuticals ETF or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute IShares Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details |
IShares Pharmaceuticals Trading Alerts and Improvement Suggestions
| IShares Pharmaceuticals generated a negative expected return over the last 90 days | |
| Latest headline from benzinga.com: Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr. | |
| The fund retains 99.89% of its assets under management (AUM) in equities |
IShares Pharmaceuticals Returns Distribution Density
The distribution of IShares Pharmaceuticals' historical returns is an attempt to chart the uncertainty of IShares Pharmaceuticals' future price movements. The chart of the probability distribution of IShares Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use iShares Pharmaceuticals ETF price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of IShares Pharmaceuticals returns is essential to provide solid investment advice for IShares Pharmaceuticals.
| Mean Return | -0.06 | Value At Risk | -1.42 | Potential Upside | 1.05 | Standard Deviation | 0.72 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of IShares Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
IShares Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to IShares Pharmaceuticals or iShares sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that IShares Pharmaceuticals' price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a IShares etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 0.46 | |
σ | Overall volatility | 0.74 | |
Ir | Information ratio | -0.26 |
IShares Pharmaceuticals Volatility Alert
iShares Pharmaceuticals ETF exhibits very low volatility with skewness of -0.31 and kurtosis of -0.07. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure IShares Pharmaceuticals' etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact IShares Pharmaceuticals' etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.IShares Pharmaceuticals Fundamentals Vs Peers
Comparing IShares Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze IShares Pharmaceuticals' direct or indirect competition across all of the common fundamentals between IShares Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as IShares Pharmaceuticals or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of IShares Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing IShares Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare IShares Pharmaceuticals to competition |
| Fundamentals | IShares Pharmaceuticals | Peer Average |
| Price To Earning | 22.36 X | 3.15 X |
| Price To Book | 1.56 X | 0.39 X |
| Price To Sales | 3.32 X | 0.33 X |
| Beta | 0.59 | |
| One Year Return | 19.10 % | (0.97) % |
| Three Year Return | 3.90 % | 3.23 % |
| Five Year Return | 8.40 % | 1.12 % |
| Ten Year Return | 4.80 % | 1.20 % |
| Net Asset | 381.08 M | 2.29 B |
| Last Dividend Paid | 0.31 | 0.14 |
| Equity Positions Weight | 99.89 % | 52.82 % |
IShares Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as IShares . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 396.89 | |||
| Daily Balance Of Power | 0.4304 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 68.75 | |||
| Day Typical Price | 68.76 | |||
| Price Action Indicator | 0.23 | |||
| Period Momentum Indicator | 0.34 |
About IShares Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell iShares Pharmaceuticals ETF? Buying financial instruments such as IShares Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having IShares Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Check out IShares Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
The market value of iShares Pharmaceuticals is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is IShares Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Pharmaceuticals' market value can be influenced by many factors that don't directly affect IShares Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.